Granulocytapheresis as a possible cancer treatment

Therapeutic Apheresis

Volumn 4, Issue 2, 2000, Pages 155-160

  Tabuchi, Takafumi ^a   Ubukata, Hideyuki ^b   Sato, Shigenori ^b   Nakata, Ichiro ^b   Goto, Yoshihisa ^b   Watanabe, Yoshinori ^b   Hashimoto, Takashi ^b   Mizuta, Toshinobu ^b   Adachi, Masakazu ^b   Soma, Tetsuo ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Cancer treatment; Granulocytapheresis; Granulocytosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER THERAPY; CLINICAL ARTICLE; CYTAPHERESIS; EXTRACORPOREAL CIRCULATION; FEMALE; FLOW RATE; GRANULOCYTOSIS; HUMAN; MALE; PRIORITY JOURNAL; VENOUS CIRCULATION;

BREAST NEOPLASMS; ESOPHAGEAL NEOPLASMS; FEMALE; GASTROINTESTINAL NEOPLASMS; GRANULOCYTES; HISTORY, 20TH CENTURY; HUMANS; LEUKAPHERESIS; MALE; SURVIVAL RATE;

EID: 6744227961     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2000.004002155.x     Document Type: Article

References (14)

1. Ubukata H, Duchi T, Soma T. The role of granulocytes in the immune response network against cancer. Biotherapy 1992;6: 776-778.
2. Petrie HT, Klassen LW, Kay D. Inhibition of human cytotoxic lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol 1985;134:230-234.
3. Shau H, Kim A. Suppression of lymphokine activated killer induction by neutrophils. J Immunol 1988;141:4395-4402.
4. Ohsawa N. CSF-producing tumors. Jpn J Int Medicine 1978; 41:1310-1316.
5. Fujii H, Sonoda Y, Maekawa T. Case study on two patients with CSF-producing cancer. Clinical Hematology 1984;25: 1653-1657.
6. Segawa K, Ueno Y, Kataoka T. A study on solid tumor growth promoted by G-CSF administration. Clinical Immunology 1992;24:295-301.
7. Tabuchi T, Ubukata H, Soma T et al. A study on the role of peripheral granulocytes in tumor-bearing hosts. Tumor and Infection 1990;3:651-657.
8. Ishikawa M. A study on experimental tumor metastases in mice with granulocytosis. Hokkaido Medical Journal 1986;62: 269-278.
9. Aeed PA, Nakajima M, Welch DR. The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762 NF mammary adenocarcinoma cells. Int J Cancer 1988;42:748.
10. Welch DR, Schissel DJ, Howrey RP et al. Tumor-elicited polymorphonuclear cells in contrast to "normal" circuladng polymorphonuclear cells sdmulate invasive and metastatic potendals of rat mammary adenocarcinoma cell. Proc Natl Acad Sci USA 1989;86:5859.
11. Seaman WE, Gindhart TD, Blackman MA et al. Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes. J Clin Invest 1982;69:876.
12. Tabuchi T, Ubukata H, Soma T et al. A study of the role of peripheral granulocytes in tumor-bearing hosts. Jpn J Surgical Medicine 1987;88:352.
13. Tabuchi T, Soma T, Yonekawa M, Komai T, Hashimoto T, Adachi M. Reduction of VX2 transplanted tumor by granulocyte depletion using extracorporeal circuladon on rabbit models. Andcancer Res 1992;12:795-798.
14. Tabuchi T, Ubukata H, Soma T et al. Depledon of peripheral granulocyte as an experimental cancer therapy. Jpn J Surgical Medicine 1992;93:179.